傳媒專區
傳媒專區 > 媒體報導 > 公院治療癌症自費藥物費用 較市民估計高19倍 組織籲及早規劃 / Citizens unaware of cancer treatment costs

公院治療癌症自費藥物費用 較市民估計高19倍 組織籲及早規劃 / Citizens unaware of cancer treatment costs

21-07-2018

公院治療癌症自費藥物費用 較市民估計高19倍 組織籲及早規劃

 

 
本港公營醫療系統一直被指超出負荷,出現病人輪候時間長、醫護人手不足等問題。在香港,癌症是頭號殺手,每10個死亡的港人,就有3個死於癌症。但有調查發現,港人低估在公立醫院治療癌症費用,逾五成人未有為未來癌症治療開支作準備。

 

香港執業專科醫生協會和病人組織「癌症資訊網」進行了一項調查,分別訪問100名癌症病人及501名非癌症患者。調查發現,受訪港人認為在公立醫院接受癌症治療,所需費用平均為1.35萬元,但癌症患者調查顯示,在公立醫院治療晚期癌症自費藥物費用,平均需付26.7萬元,比普通市民的預計多19倍。

另外,只有約四成人為未來癌症治療開支作準備,但當中約兩成人以強積金或退休金作準備。

組織建議,政府和市民均應儘早開展未來癌症治療規劃,應對日益增加的癌症治療開支。

 

——————————————————————————————————-

Citizens unaware of cancer treatment costs

 

Hongkongers lack awareness of the full cost of getting cancer treatment, according to a survey.

The Cancer Information Hong Kong Charity Foundation interviewed 500 people and asked them how much they thought would be the overall cost of terminal stage colorectal cancer treatment.

The respondents expected the cost of treatment in the vicinity of HK$60,000 on average at public hospitals.

But the actual cost could exceed HK$270,000 and the amount still doesn’t include target therapy and immunotherapy since the Hospital Authority does not offer these services for free.

Poll respondents estimated cancer treatment in private hospitals to cost HK$400,000, but the actual cost is more than three times higher at HK$1.3 million.

Alan Ng Wai-lun, the foundation’s chairman, said more than half of the survey respondents have revealed that they were not setting aside any funds for cancer treatments.

Among the poll respondents, 57 percent said they have prepared for cancer by setting up savings. The rest said they would rely on medical insurance, the Mandatory Provident Fund and financial investments.

Asked what they would do if their insurance cover fails to pay for the costs of cancer treatment, 69 percent of the respondents said they would opt for cheaper public hospital services, and 11 percent said they would sell their apartments to raise funds.

The foundation also surveyed 100 cancer patients and 56 percent of the respondents said they had heard stories about fellow cancer sufferers forced to terminate treatments as they could no longer afford them.

Under the Voluntary Healthcare Insurance Scheme, which will be launched next year, cancer patients can claim a maximum of HK$80,000 for therapies.

Clinical oncology specialist Maverick Tsang Wai-kong said most target therapies cost between HK$30,000 and HK$40,000 per treatment.

Jeffrey Pong Chiu-fai of the Hong Kong Practicing Specialists Association has admitted that cancer services at public hospitals were often fully occupied.

“There are only around 100 clinical oncology specialists under the Hospital Authority and the doctor-patient ratio is one to 2,172,” he said.

 

文章來自: (中) HK01     (Eng) The Standard

 

 

 

疑難排解

會員註冊


或許你會想看
棄百萬年薪後確診患癌 表達藝術治療師 劫後餘生望助同路人
棄百萬年薪後確診患癌 表達藝術治療師 劫後餘生望助同路人 作為打工仔,收入往往跟工作量及工作壓力成正比,蘇瑞雯 […]
中大研發嶄新治療組合 帶領亞洲策略性抗擊膽管癌
中大研發嶄新治療組合 帶領亞洲策略性抗擊膽管癌 2022年8月8日 1 中大醫學院領導的一項多中心臨床研究發現 […]
有藥冇錢醫|基層抗癌悲歌 新藥未納入安全網資助 病人或等到死
有藥冇錢醫|基層抗癌悲歌 新藥未納入安全網資助 病人或等到死 65歲的枝媽乳癌復發,其23歲的兒子Vincen […]
2022年施政報告公眾諮詢 : 快捷藥物引進機制與藥物撥款資助建議
2022年施政報告公眾諮詢 : 快捷藥物引進機制與藥物撥款資助建議 致 行政長官李家超先生: 恭賀成為香港特別 […]
中大發現多發性骨髓瘤發病率上升 以高收入國家的男性長者升幅最為顯著
中大發現多發性骨髓瘤發病率上升 以高收入國家的男性長者升幅最為顯著 2022年8月4日 中大醫學院與環太平洋大 […]
李慧敏醫生
李慧敏醫生 Dr. Lee Wai Man Sarah         […]
宏利香港推出「守護無間危疾保」 提供多重守護及市場首創之靈活癌症賠償方案
宏利香港推出「守護無間危疾保」 提供多重守護及市場首創之靈活癌症賠償方案 新產品為客戶提供康復支援、滿足確診後 […]
乙型肝炎|乙肝帶病毒者 九成唔知自己中招
乙型肝炎|乙肝帶病毒者 九成唔知自己中招 乙肝帶病毒者 九成唔知自己中招 研究指出7.2%人口是乙型肝炎帶病毒 […]
世界肝炎日|有團體辦展覽活動 200個名額即場驗血測乙肝
世界肝炎日|有團體辦展覽活動 200個名額即場驗血測乙肝 癌症資訊網慈善基金和香港肝康會合作舉辦「全城無肝炎」 […]
呂卓如醫生
呂卓如醫生 Dr. Lui Cheuk Yu, Louisa       &nb […]
乙肝要及時治療 減低肝硬化肝癌風險
乙肝要及時治療 減低肝硬化肝癌風險 本港自八十年代開始為初生嬰兒注射乙型肝炎疫苗,令整體帶病毒人口由以往的14 […]
竺兆豪醫生
竺兆豪 醫生 Dr CHOK Siu Ho Kenneth       &nbs […]